| Date Checked | 2026-02-19 22:17:06 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 3.87% |
| Dividend Date | 2025-12-15 |
| Symbol | VTRS |
| AssetType | Common Stock |
| Name | Viatris Inc |
| Description | Viatris Inc. (VTRS) is a prominent global healthcare provider headquartered in Canonsburg, Pennsylvania, formed through the strategic merger of Mylan and Pfizer's Upjohn division. The company boasts a robust portfolio encompassing generic, branded, and over-the-counter products, aiming to enhance patient access to high-quality healthcare across more than 165 countries. Viatris is dedicated to addressing diverse health challenges through innovative solutions and a comprehensive distribution network, all while focusing on cost-effectiveness and sustainability within the healthcare system. As it navigates an evolving industry landscape, Viatris remains committed to improving patient outcomes and advancing healthcare accessibility worldwide. |
| CIK | 1792044 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Address | ROBERT J. COURY GLOBAL CENTER, CANONSBURG, PA, UNITED STATES, 15317 |
| OfficialSite | https://www.viatris.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 14384662000 |
| EBITDA | 4037300000 |
| PERatio | 0 |
| PEGRatio | 0.0728 |
| BookValue | 13.13 |
| DividendPerShare | 0.48 |
| EPS | -3.13 |
| RevenuePerShareTTM | 11.96 |
| ProfitMargin | -0.261 |
| OperatingMarginTTM | 0.108 |
| ReturnOnAssetsTTM | 0.0218 |
| ReturnOnEquityTTM | -0.211 |
| RevenueTTM | 14124400000 |
| GrossProfitTTM | 5659300000 |
| DilutedEPSTTM | -3.13 |
| QuarterlyEarningsGrowthYOY | -0.706 |
| QuarterlyRevenueGrowthYOY | 0.002 |
| AnalystTargetPrice | 12.67 |
| AnalystRatingStrongBuy | 1 |
| AnalystRatingBuy | 3 |
| AnalystRatingHold | 6 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | - |
| ForwardPE | 5.09 |
| PriceToSalesRatioTTM | 1.018 |
| PriceToBookRatio | 0.943 |
| EVToRevenue | 1.976 |
| EVToEBITDA | 11.16 |
| Beta | 0.792 |
| 52WeekHigh | 12.72 |
| 52WeekLow | 6.6 |
| 50DayMovingAverage | 11.12 |
| 200DayMovingAverage | 9.69 |
| SharesOutstanding | 1151770000 |
| SharesFloat | 1144180000 |
| PercentInsiders | 0.280 |
| PercentInstitutions | 86.862 |
| ExDividendDate | 2025-11-24 |
| etoro | 1 |
| dateChecked | 2026-02-19 22:17:06 |
| fresh | 1 |